North America Hip Reconstruction Market Outlook to 2020 @http://www.researchmoz.us/north-america-hip-reconstruction-market-outlook-to-2020-report.html

1. North America Hip Reconstruction Market Outlook to 2020
North America Hip Reconstruction Market Outlook to 2020
Summary
GlobalDatas new report, "North America Hip Reconstruction Market Outlook to 2020", provides key market data on the North America Hip Reconstruction
market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Primary Hip
Replacement, Revision Hip Replacement, Partial Hip Replacement and Hip Resurfacing.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market
participants, pipeline products, and news and deals related to the Hip Reconstruction market wherever available.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipmentbased models to estimate and
forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to
establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and
treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipmentbased forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare
facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital
equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution
share data and analysis.
Scope
- Market size for Hip Reconstruction market categories Primary Hip Replacement, Revision Hip Replacement, Partial Hip Replacement and Hip Resurfacing.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to
2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the North America Hip Reconstruction market.
- Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group,
Inc.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Uction Market, Canada 27
4.1 Hip Reconstruction Market, Canada, Revenue ($m), 2005-2012 27
4.2 Hip Reconstruction Market, Canada, Revenue ($m), 2012-2020 29
4.2.1 Primary Hip Replacement Market, Canada, Revenue ($m), By Segment, 2005-2012 31
4.2.2 Primary Hip Replacement Market, Canada, Revenue ($m), By Segment, 2012-2020 33
4.3 Hip Reconstruction Market, Canada, Volume (units), 2005-2012 35
4.4 Hip Reconstruction Market, Canada, Volume (units), 2012-2020 37
4.4.1 Primary Hip Replacement Market, Canada, Volume (units), By Segment, 2005-2012 39
4.4.2 Primary Hip Replacement Market, Canada, Volume (units), By Segment, 2012-2020 41
4.5 Hip Reconstruction Market, Canada, Average Price ($), 2005-2020 43
4.6 Hip Reconstruction Market, Canada, Distribution Share By Revenue ($m), 2011-2012 45
4.7 Hip Reconstruction Market, Canada, Company Share By Revenue ($m), 2011-2012 46
5 Hip Reconstruction Market, Mexico 48
5.1 Hip Reconstruction Market, Mexico, Revenue ($m), 2005-2012 48
5.2 Hip Reconstruction Market, Mexico, Revenue ($m), 2012-2020 50
5.2.1 Primary Hip Replacement Market, Mexico, Revenue ($m), By Segment, 2005-2012 52
5.2.2 Primary Hip Replacement Market, Mexico, Revenue ($m), By Segment, 2012-2020 54
5.3 Hip Reconstruction Market, Mexico, Volume (units), 2005-2012 56
5.4 Hip Reconstruction Market, Mexico, Volume (units), 2012-2020 58
5.4.1 Primary Hip Replacement Market, Mexico, Volume (units), By Segment, 2005-2012 60
5.4.2 Primary Hip Replacement Market, Mexico, Volume (units), By Segment, 2012-2020 62
North America Hip Reconstruction Market Outlook to 2020

2. 5.5 Hip Reconstruction Market, Mexico, Average Price ($), 2005-2020 64
5.6 Hip Reconstruction Market, Mexico, Distribution Share By Revenue ($m), 2011-2012 66
5.7 Hip Reconstruction Market, Mexico, Company Share By Revenue ($m), 2011-2012 67
6 Hip Reconstruction Market, United States 69
6.1 Hip Reconstruction Market, United States, Revenue ($m), 2005-2012 69
6.2 Hip Reconstruction Market, United States, Revenue ($m), 2012-2020 71
6.2.1 Primary Hip Replacement Market, United States, Revenue ($m), By Segment, 2005-2012 73
6.2.2 Primary Hip Replacement Market, United States, Revenue ($m), By Segment, 2012-2020 75
6.3 Hip Reconstruction Market, United States, Volume (units), 2005-2012 77
6.4 Hip Reconstruction Market, United States, Volume (units), 2012-2020 79
6.4.1 Primary Hip Replacement Market, United States, Volume (units), By Segment, 2005-2012 81
6.4.2 Primary Hip Replacement Market, United States, Volume (units), By Segment, 2012-2020 83
6.5 Hip Reconstruction Market, United States, Average Price ($), 2005-2020 85
6.6 Hip Reconstruction Market, United States, Distribution Share By Revenue ($m), 2011-2012 87
6.7 Hip Reconstruction Market, United States, Company Share By Revenue ($m), 2011-2012 88
7 Overview Of Key Companies In North America Hip Reconstruction Devices Market 90
7.1 Depuy Companies 90
7.1.1 Company Overview 90
7.2 Stryker Corporation 90
7.2.1 Company Overview 90
7.3 Zimmer Holdings, Inc. 90
7.3.1 Company Overview 90
7.4 Biomet, Inc. 91
7.4.1 Company Overview 91
7.5 Smith & Nephew Plc 91
7.5.1 Company Overview 91
7.6 Wright Medical Group, Inc. 92
7.6.1 Company Overview 92
8 Hip Reconstruction Market Pipeline Products 93
9 Recent Developments 94
9.1 Corporate Communications 94
9.1.1 Dec 16, 2013: Zimmer Holdings Names Paul Bisaro To Board Of Directors 94
9.1.2 Oct 28, 2013: President And Ceo Announced For Hf West Bloomfield Hospital 94
9.1.3 Oct 14, 2013: Exactech Names Orthopaedic Executive Bill Shopoff As Vice President U.s. Sales; Industry Veteran Bob Purcell Retires After 40+ Years In
Healthcare 95
9.1.4 Aug 19, 2013: Orthofix Receives Expected Nasdaq Notice Related To Late Filing Of Form 10-q 95
9.1.5 Jul 18, 2013: Mako Surgical Corp. Announces Management Changes 96
9.1.6 Jul 08, 2013: Mako Surgical Announces Additions To Board Of Directors 96
9.1.7 Jun 03, 2013: Mako Surgical Announces Addition Of Senior Executive To Management Team 97
9.1.8 May 21, 2013: Henry Ford Health System Abandons Merger Plans With Beaumont Health 97
9.1.9 May 09, 2013: Zimmer Eliminates Approximately 50 Full Time Jobs 98
9.1.10 Apr 08, 2013: Stryker Names William Jellison As Cfo 98
9.1.11 Mar 11, 2013: Amedica Appoints Karl Farnsworth As Cfo 99
9.1.12 Feb 25, 2013: Zimmer Spine Launches Zimmer Dto 5.5 System 99
9.1.13 Feb 21, 2013: Mako Surgical Announces Appointment Of Christopher R. Marrus As Senior Vice President Of Sales 100
9.1.14 Feb 01, 2013: Endosenses Tacticath Quartz Contact-force Sensing Ablation Catheter Used To Perform First Case In Us 100
9.2 Financial Announcements 101
9.2.1 Jan 08, 2014: Biomet Announces Second Quarter Of Fiscal 2014 Financial Results 101
9.2.2 Dec 16, 2013: Zimmer Announces Fourth Quarter Dividend And New Share Repurchase Program 102
9.2.3 Nov 05, 2013: Mako Surgical Corp. Reports Operating Results For The Third Quarter 2013 102
9.2.4 Oct 31, 2013: Isolite Systems Launches Isovac Dental Isolation Adapter 104
9.2.5 Oct 29, 2013: Arthrocare Reports Third Quarter 2013 Financial Results 105
9.2.6 Oct 25, 2013: Arthrocare Announces Date For Third Quarter 2013 Financial Results Press Release And Conference Call 107
9.2.7 Oct 24, 2013: Zimmer Holdings Reports Third Quarter 2013 Financial Results 107
9.2.8 Oct 23, 2013: Exactech Q3 Net Income Up 25% To $3.2 Million; Diluted Eps $0.23 Vs. $0.19; Worldwide Sales Up 9% To $55.7 Million; U.s. Sales
Increased 11% 108
9.2.9 Oct 17, 2013: Stryker Reports Third Quarter 2013 Results 109
9.2.10 Oct 10, 2013: Zimmer Holdings Announces Live Audio Webcast And Conference Call Of Third Quarter 2013 Results 111
9.2.11 Oct 08, 2013: Devon Medical Announces Global Availability Of Foot Dressing For Negative Pressure Wound Therapy 111
9.2.12 Oct 08, 2013: Biomet Announces First Quarter Of Fiscal 2014 Financial Results 112
9.2.13 Oct 08, 2013: Exactech Schedules Third Quarter 2013 Earnings Release And Conference Call 114
9.2.14 Sep 24, 2013: Biomet Announces Fiscal Year 2014 First Quarter Conference Call 114
9.2.15 Sep 08, 2013: Successful Live Case And International Recognition For The Innovative And Unique Urological Stents Of Allium Medical 114
9.2.16 Aug 29, 2013: Biomet Announces Fourth Quarter And Fiscal Year 2013 Final Financial Results 117
9.2.17 Aug 05, 2013: Arthrocare Reports Second Quarter 2013 Financial Results 118
9.2.18 Aug 02, 2013: Arthrocare Announces Date For Second Quarter 2013 Financial Results Press Release And Conference Call 119
9.2.19 Jul 30, 2013: Mako Surgical Corp. Reports Operating Results For The Second Quarter 2013 120
9.2.20 Jul 25, 2013: Zimmer Reports Second Quarter 2013 Financial Results 122
North America Hip Reconstruction Market Outlook to 2020

3. 9.2.21 Jul 24, 2013: Exactech Q2 Net Income Up 23% To $3.7 Million. Diluted Eps $0.27 Vs. $0.23. Worldwide Sales Up 10% To $60.6 Million. U.s. Sales
Increased 13% 123
9.2.22 Jul 15, 2013: Mako Surgical Corp. Schedules Second Quarter 2013 Earnings Release And Conference Call For Tuesday, July 30, 2013 124
9.2.23 Jul 11, 2013: Biomet Announces Fourth Quarter And Fiscal Year 2013 Preliminary Financial Results 124
9.2.24 Jul 10, 2013: Exactech Schedules Second Quarter 2013 Earnings Release And Conference Call 126
9.2.25 Jun 17, 2013: Covidien Announces Publication Of Final Results Of Pipeline Embolization Device Pivotal Study 126
9.2.26 Jun 04, 2013: Neuros Medical Announces Pilot Study Results On Electrical Nerve Block Technology 129
9.3 Government And Public Interest 129
9.3.1 Jan 06, 2014: Zimmer Holdings To Present At 32nd Annual J.p. Morgan Healthcare Conference 129
9.3.2 Jan 06, 2014: Arthrocare Announces Participation In Investor Conference 129
9.3.3 Dec 09, 2013: Henry Ford Hospital Performs Minimally Invasive Laser Brain Surgeries 130
9.3.4 Nov 26, 2013: Stryker R&d Executive To Speak At Clinical Research Conference On December 4, 2013 131
9.3.5 Nov 25, 2013: Arthrocare Announces Participation In Investor Conference 132
9.3.6 Nov 20, 2013: Biomet To Present At Bank Of America Merrill Lynch 2013 Leveraged Finance Conference 132
9.3.7 Sep 05, 2013: Mako Surgical To Present At The Morgan Stanley Global Healthcare Conference 132
9.3.8 Aug 30, 2013: Stryker To Present At Investor Conference 132
9.3.9 Aug 20, 2013: Zimmer Holdings To Present At The Bank Of America Merrill Lynch 2013 Healthcare Conference 132
9.3.10 Aug 20, 2013: Zimmer Holdings To Present At Ubs Best Of Americas Conference 2013 132
9.3.11 Aug 20, 2013: Zimmer Holdings To Present At Morgan Stanley 2013 Global Healthcare Conference 132
9.3.12 Aug 06, 2013: Exactech Announces Investor Presentation At Canaccord Genuity Growth Conference 133
9.3.13 May 30, 2013: Radiation Oncology Receives Acr Accreditation 133
9.3.14 Feb 15, 2013: Fda Proposes Pma For Mom Hip Systems 133
9.4 Legal And Regulatory 134
9.4.1 Nov 12, 2013: Johnson & Johnson To Settle Hip Implant Lawsuits For $4bn 134
9.4.2 Oct 29, 2013: Depuy Pinnacle Lawsuit News: Bernstein Liebhard Comments On Impending Metal-on-metal Hip Ban In Uk Hospitals 135
9.4.3 Sep 23, 2013: Henry Ford Medical Laboratories Receive Prestigious Accreditation 135
9.4.4 Aug 16, 2013: Glancy Binkow & Goldberg Announces Class Action Lawsuit Against Orthofix International 136
9.4.5 Jul 15, 2013: Josephine Ford Cancer Institute Earns Star Program Certification 136
9.4.6 Jul 05, 2013: Kentucky Plaintiff Claims Stryker Rejuvenate Failure 137
9.4.7 May 31, 2013: Us Court To Render Decision On Consolidated Proceedings Of Stryker Hip Lawsuits 138
9.4.8 Mar 19, 2013: Mako Announces Patent Enforcement Actions Against Stanmore Entities 138
9.4.9 Mar 08, 2013: Los Angeles Jury Awards $8.3m In First Depuy Asr Hip Implant Trial 138
9.4.10 Feb 22, 2013: J&j Says Federal Prosecutors Investigating Marketing Of Depuy Hip Implants 139
9.4.11 Feb 15, 2013: Johnson & Johnson Recalls Adept Line Of All-metal Hip Replacement Systems From Outside Us 139
9.4.12 Jan 25, 2013: Johnson & Johnson Metal Hip Implant Trial Begins In Los Angeles 139
9.5 Other Significant Developments 140
9.5.1 Jan 20, 2014: Cataract Surgery With The Wavetec Vision's Ora System Outperforms Conventional Biometry In A Comparative Effectiveness Study
Published In The Peer-reviewed Journal Ophthalmology 140
9.5.2 Sep 10, 2013: Level 1 Trauma Verification Renewed For Henry Ford Hospital 141
9.5.3 Aug 02, 2013: Henry Ford Relocates Womens Health Services In Dearborn 142
9.5.4 May 16, 2013: Johnson & Johnson Discontinues Sales Of Ultamet Metal-on-metal And Complete Ceramic-on-metal Hip Systems 142
9.6 Product News 143
9.6.1 Dec 16, 2013: Henry Ford Implants New Defibrillator For Sudden Cardiac Arrest 143
9.7 Strategy And Business Planning 144
9.7.1 Mar 27, 2013: Biomet Revokes Plans To Spin-off Dental Business 144
9.7.2 Feb 06, 2013: Home Dialysis Training Facility Opens In Novi 144
10 Appendix 146
10.1 Research Methodology 147
10.1.1 Coverage 147
10.1.2 Secondary Research 147
10.1.3 Primary Research 148
10.1.4 Market Modeling And Forecasting 149
10.1.5 Company Share Analysis 152
10.1.6 Distribution Share Analysis 153
10.2 Expert Panels 153
10.3 Globaldata Consulting 154
10.4 Contact Us 154
10.5 Disclaimer 154
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
North America Hip Reconstruction Market Outlook to 2020

4. Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
North America Hip Reconstruction Market Outlook to 2020